熱門資訊> 正文

Denali Therapeutics在定价2亿美元股权发行后股价下跌

2025-12-10 18:34

Denali Therapeutics(DNLI) 0

Denali Therapeutics priced its public offering of 9.14M shares at $17.50 each, plus pre-funded warrants to purchase around 2.29M shares at $17.49 per pre-funded warrant.
Click here to read more.

More on Denali Therapeutics

Denali Therapeutics Inc. (DNLI) Analyst/Investor Day Transcript
Denali Therapeutics Inc. (DNLI) Analyst/Investor Day - Slideshow
Denali: Regulatory Delay Is A Strategic Opportunity
Denali Therapeutics prices stock offering at $17.50 per share
Denali Therapeutics announces $200M proposed offering of common stock and pre-funded warrants

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。